Document is current
Any future updates will be listed below
-
Authors
Husby, Simon
Favero, Francesco https://orcid.org/0000-0003-3684-2659
Nielsen, Christian
Sørensen, Betina S.
Bæch, John
Grell, Kathrine
Hansen, Jakob W.
Rodriguez-Gonzalez, Francisco G.
Haastrup, Eva K.
Fischer-Nielsen, Anne
Andersen, Pernille
Arboe, Bente
Sækmose, Susanne G.
Hansen, Per B.
Christiansen, Ilse
Clasen-Linde, Erik
Meldgaard, Lene
Ebbesen, Lene H.
Segel, Erik K.
Josefsson, Pär
Thorsgaard, Michael
El-Galaly, Tarec C.
Brown, Peter
Weischenfeldt, Joachim
Larsen, Thomas S.
Grønbæk, Kirsten
-
Funding
Funding for this research was provided by:
Region Hovedstaden (01012017)
Novo Nordisk Fonden (NNF17CC0027852)
- License Information
-
More Information
Article History
Received: 27 September 2019
Revised: 29 February 2020
Accepted: 4 March 2020
First Online: 20 March 2020
Compliance with ethical standards
:
: SH received grant funding from Rigshospitalet and Danish Capital Regions Research Fond. KG received grant funding from The Danish Cancer Society, the Novo Nordisk Foundation, and Greater Copenhagen Health Science Partners. KG serves on the advisory boards for Celgene and Otsuka Pharmaceutical, and has received travel grants from Celgene. TCEG was employed by F. Hoffmann–La Roche, Ltd, Basel, Switzerland from January 2019. TCEG has received travel funding from Roche (2016) and Takeda (2017). TSL has served on advisory boards for Takeda and Roche. PB has served on advisory boards for Celgene and Roche. All other authors declare no conflict of interest.
